Toll Free: 1-888-928-9744
Published: Jul, 2016 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Caladrius Biosciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Caladrius Biosciences, Inc. - Product Pipeline Review - 2016', provides an overview of the Caladrius Biosciences, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Caladrius Biosciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Caladrius Biosciences, Inc. - The report provides overview of Caladrius Biosciences, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Caladrius Biosciences, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Caladrius Biosciences, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Caladrius Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Caladrius Biosciences, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Caladrius Biosciences, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Caladrius Biosciences, Inc. Snapshot 4 Caladrius Biosciences, Inc. Overview 4 Key Information 4 Key Facts 4 Caladrius Biosciences, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Caladrius Biosciences, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Caladrius Biosciences, Inc. - Pipeline Products Glance 11 Caladrius Biosciences, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Caladrius Biosciences, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Caladrius Biosciences, Inc. - Drug Profiles 15 CLBS-03 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CLBS-12 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Stem Cell Therapy for AMD and Retinitis Pigmentosa 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Caladrius Biosciences, Inc. - Pipeline Analysis 19 Caladrius Biosciences, Inc. - Pipeline Products by Route of Administration 19 Caladrius Biosciences, Inc. - Pipeline Products by Molecule Type 20 Caladrius Biosciences, Inc. - Recent Pipeline Updates 21 Caladrius Biosciences, Inc. - Dormant Projects 24 Caladrius Biosciences, Inc. - Discontinued Pipeline Products 25 Discontinued Pipeline Product Profiles 25 CLBS-10 25 Caladrius Biosciences, Inc. - Locations And Subsidiaries 26 Head Office 26 Other Locations & Subsidiaries 26 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables
Caladrius Biosciences, Inc. , Key Information 4 Caladrius Biosciences, Inc. , Key Facts 4 Caladrius Biosciences, Inc. - Pipeline by Indication, 2016 6 Caladrius Biosciences, Inc. - Pipeline by Stage of Development, 2016 7 Caladrius Biosciences, Inc. - Monotherapy Products in Pipeline, 2016 8 Caladrius Biosciences, Inc. - Partnered Products in Pipeline, 2016 9 Caladrius Biosciences, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 10 Caladrius Biosciences, Inc. - Phase II, 2016 11 Caladrius Biosciences, Inc. - Phase I, 2016 12 Caladrius Biosciences, Inc. - Preclinical, 2016 13 Caladrius Biosciences, Inc. - Discovery, 2016 14 Caladrius Biosciences, Inc. - Pipeline by Route of Administration, 2016 19 Caladrius Biosciences, Inc. - Pipeline by Molecule Type, 2016 20 Caladrius Biosciences, Inc. - Recent Pipeline Updates, 2016 21 Caladrius Biosciences, Inc. - Dormant Developmental Projects,2016 24 Caladrius Biosciences, Inc. - Discontinued Pipeline Products, 2016 25 Caladrius Biosciences, Inc. , Other Locations 26 Caladrius Biosciences, Inc. , Subsidiaries 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.